$80.00
-0.50[-0.62%]
At close: May 14
$80.00
0[0.00%]
After Hours: 5:37PM EDT
Biomarin Pharmaceutical
(NASDAQ:BMRN)Biomarin Pharmaceutical Stock (NASDAQ:BMRN), Earnings Estimates, EPS, and Revenue
Biomarin Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 24
EPS
$0.710
Quarterly Revenue
$648.8M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.5B
Analyze the earnings history of Biomarin Pharmaceutical using advanced sorting and filters.
No data available to display
ticker | Company Name | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Date | Get Alert |
|---|
FAQ
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical (BMRN) is scheduled to report earnings on July 29, 2024. The last reported earnings were for reported on April 24, 2024 for Q1.
What were the latest earnings per share (EPS) for Biomarin Pharmaceutical (NASDAQ:BMRN)?
The Actual EPS was $0.71, which beat the estimate of $0.34.
What were Biomarin Pharmaceutical’s (NASDAQ:BMRN) revenues?
The Actual Revenue was $648.8M, which missed the estimate of $651.8M.
Browse earnings estimates, EPS, and revenue on all stocks.